Nexalin Technology, Inc. SEC filings NXL

Nexalin Technology, Inc. has 204 filings in SEC EDGAR's recent list, going back to Aug 9, 2011. Its latest annual report, Form ARS, was filed on Jul 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (other events). The company's fiscal year ends on December 31.

Nexalin Technology, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D Ownership over 5% (active) Sep 3, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 27, 2026 —
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Sep 30, 2025 Sep 29, 2025
4 Insider transaction Sep 30, 2025 Sep 29, 2025
4 Insider transaction Sep 30, 2025 Sep 29, 2025
4 Insider transaction Sep 30, 2025 Sep 29, 2025
4 Insider transaction Sep 12, 2025 Sep 12, 2025
4 Insider transaction Sep 12, 2025 Sep 12, 2025
4 Insider transaction Sep 12, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 10, 2025 —
3 Initial insider ownership Aug 7, 2025 Aug 1, 2025
4 Insider transaction Jul 21, 2025 Jul 17, 2025
4 Insider transaction Mar 13, 2025 Mar 12, 2025
4 Insider transaction Feb 27, 2025 Feb 26, 2025
4 Insider transaction Feb 27, 2025 Feb 26, 2025
5 Annual insider ownership Feb 10, 2025 Dec 31, 2024
4 Insider transaction Feb 5, 2025 Feb 4, 2025
4 Insider transaction Feb 4, 2025 Feb 4, 2025
5 Annual insider ownership Jan 29, 2025 Dec 31, 2024
5 Annual insider ownership Jan 29, 2025 Dec 31, 2024
4 Insider transaction Jan 29, 2025 Jan 28, 2025
4 Insider transaction Jan 24, 2025 Jan 13, 2025
4 Insider transaction Oct 30, 2024 Oct 28, 2024
4/A Form 4/a Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Sep 25, 2024 Sep 23, 2024
4/A Form 4/a Sep 25, 2024 Sep 28, 2022
4 Insider transaction Aug 15, 2024 Aug 13, 2024
4 Insider transaction Jul 1, 2024 Jun 28, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 12, 2024 Jun 10, 2024
4 Insider transaction Oct 5, 2023 Sep 16, 2022
4 Insider transaction Oct 5, 2023 Sep 16, 2022
4 Insider transaction Oct 5, 2023 Sep 16, 2022
4 Insider transaction Oct 5, 2023 Sep 28, 2022
4/A Form 4/a Jun 30, 2023 Sep 16, 2022
4/A Form 4/a Jun 30, 2023 Sep 15, 2022
4/A Form 4/a Jun 30, 2023 Sep 16, 2022
3/A Form 3/a Jun 30, 2023 Sep 15, 2022
3/A Form 3/a Jun 30, 2023 Sep 15, 2022
4 Insider transaction Sep 29, 2022 Sep 28, 2022
4/A Form 4/a Sep 22, 2022 Sep 15, 2022
4 Insider transaction Sep 20, 2022 Sep 16, 2022
4 Insider transaction Sep 20, 2022 Sep 16, 2022
4 Insider transaction Sep 20, 2022 Sep 16, 2022
4 Insider transaction Sep 20, 2022 Sep 16, 2022
4 Insider transaction Sep 20, 2022 Sep 16, 2022
3 Initial insider ownership Sep 19, 2022 Sep 15, 2022
3 Initial insider ownership Sep 19, 2022 Sep 15, 2022
3 Initial insider ownership Sep 19, 2022 Sep 15, 2022
3 Initial insider ownership Sep 19, 2022 Sep 15, 2022
3 Initial insider ownership Sep 19, 2022 Sep 15, 2022
3 Initial insider ownership Sep 19, 2022 Sep 15, 2022

Showing 60 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NXL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
, Emerging growth company
SEC CIK
1527352

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.